• Categories:

    PEACE-3 trial demonstrates significant overall survival benefit in patients with metastatic castration-resistant prostate cancer with bone metastases

  • Rare disease day rare cancers
    Categories:

    EORTC celebrates Rare Disease Day: Addressing unmet needs in rare cancers

  • First Site Activated in EORTC RENALUT Clinical Trial on Metastatic Clear Cell Renal Cell Carcinoma

  • World Cancer Day
    Categories:

    World Cancer Day: How clinical cancer research changes lives

  • New international study shows access to patient-reported outcome data improves the consistency of the evaluation of cancer treatment adverse events

  • Categories:

    First Site Activated and First Patient Randomised in new brain cancer study VIGOR – EORTC‑2427‑BTG

  • Categories:

    EORTC and EMA, jointly with international stakeholders, have published a multistakeholder roadmap to accelerate treatment optimisation in oncology

  • Young adult with health professional, filling in a quality of life questionnaire

    New EORTC quality of life questionnaire for adolescents and young adults with cancer